BioIQ CEO Justin Bellante Speaks with CBS46 on COVID19 Testing Efforts

BioIQ CEO Justin Bellante recently spoke with CBS46 News reporter Brittany Miller about BioIQ’s work to bring COVID-19 testing resources to at-risk individuals working on the front lines to battle the disease.

BioIQ has over a decade of experience helping health plans, employers and government agencies engage members, employees and constituents in health testing programs targeting high-cost conditions such as colorectal cancer, diabetes and kidney disease. The company recently turned its knowledge, attention and resources to fighting COVID-19.

BioIQ works with over 30 health plans representing two-thirds of U.S. lives.  The company is using its existing infrastructure and relationships with an integrated network of laboratories to increase access to COVID-19 testing resources.

The CBS46 News interview comes on the heels of BioIQ’s release of a COVID-19 solution for health plans, employers and regional government agencies that includes the management of analytics, testing, education and care navigation related to the disease. The offering expands availability of testing and support to those who need them most, including front-line responders and healthcare providers.

Learn more about the company’s COVID-19 solution here: BioIQ Announces COVID-19 Suite of Solutions for Health Plans, Employers and Government Agencies